Benitec Biopharma Inc.
Benitec Biopharma Inc.
Your view on BNTC
Overview
What the company does, where it operates, and who runs it.
About Benitec Biopharma Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Jerel A. Banks
- Headquarters
- 3940 Trust Way, Hayward, CA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Jerel A. Banks
- Headquarters
- 3940 Trust Way, Hayward, CA, US
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.